Apex Healthcare Berhad Past Earnings Performance
Past criteria checks 2/6
Apex Healthcare Berhad has been growing earnings at an average annual rate of 45.2%, while the Pharmaceuticals industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 8.2% per year. Apex Healthcare Berhad's return on equity is 11%, and it has net margins of 9.3%.
Key information
45.2%
Earnings growth rate
45.0%
EPS growth rate
| Pharmaceuticals Industry Growth | 7.7% |
| Revenue growth rate | 8.2% |
| Return on equity | 11.0% |
| Net Margin | 9.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation
May 08
Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025
Aug 28Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09
Apr 19Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09
Feb 25Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year
Aug 24Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly
May 11Is Apex Healthcare Berhad (KLSE:AHEALTH) A Smart Pick For Income Investors?
Apr 08Estimating The Intrinsic Value Of Apex Healthcare Berhad (KLSE:AHEALTH)
Mar 11Does Apex Healthcare Berhad (KLSE:AHEALTH) Deserve A Spot On Your Watchlist?
Feb 26Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?
Feb 11
These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well
Jan 25Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio
Jan 07Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?
Dec 20Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment
Dec 05Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters
Nov 20Revenue & Expenses Breakdown
How Apex Healthcare Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 962 | 89 | 128 | 0 |
| 31 Mar 24 | 939 | 395 | 126 | 0 |
| 31 Dec 23 | 936 | 398 | 124 | 0 |
| 30 Sep 23 | 917 | 413 | 122 | 0 |
| 30 Jun 23 | 913 | 415 | 118 | 0 |
| 31 Mar 23 | 908 | 109 | 116 | 0 |
| 31 Dec 22 | 878 | 101 | 112 | 0 |
| 30 Sep 22 | 855 | 87 | 108 | 0 |
| 30 Jun 22 | 834 | 74 | 107 | 0 |
| 31 Mar 22 | 807 | 63 | 102 | 0 |
| 31 Dec 21 | 771 | 59 | 98 | 0 |
| 30 Sep 21 | 735 | 53 | 94 | 0 |
| 30 Jun 21 | 693 | 53 | 87 | 0 |
| 31 Mar 21 | 685 | 54 | 90 | 0 |
| 31 Dec 20 | 699 | 56 | 93 | 0 |
| 30 Sep 20 | 708 | 56 | 97 | 0 |
| 30 Jun 20 | 719 | 56 | 101 | 0 |
| 31 Mar 20 | 704 | 56 | 100 | 0 |
| 31 Dec 19 | 689 | 53 | 99 | 0 |
| 30 Sep 19 | 681 | 56 | 98 | 0 |
| 30 Jun 19 | 666 | 56 | 97 | 0 |
| 31 Mar 19 | 662 | 57 | 97 | 0 |
| 31 Dec 18 | 653 | 59 | 97 | 0 |
| 30 Sep 18 | 642 | 55 | 96 | 0 |
| 30 Jun 18 | 635 | 51 | 95 | 0 |
| 31 Mar 18 | 634 | 48 | 94 | 0 |
| 31 Dec 17 | 620 | 44 | 90 | 0 |
| 30 Sep 17 | 612 | 38 | 89 | 0 |
| 30 Jun 17 | 597 | 36 | 87 | 0 |
| 31 Mar 17 | 588 | 35 | 86 | 0 |
| 31 Dec 16 | 581 | 35 | 85 | 0 |
| 30 Sep 16 | 571 | 42 | 84 | 0 |
| 30 Jun 16 | 557 | 39 | 82 | 0 |
| 31 Mar 16 | 534 | 36 | 79 | 0 |
| 31 Dec 15 | 527 | 34 | 79 | 0 |
| 30 Sep 15 | 516 | 30 | 78 | 0 |
| 30 Jun 15 | 510 | 32 | 77 | 0 |
| 31 Mar 15 | 508 | 33 | 76 | 0 |
| 31 Dec 14 | 499 | 34 | 75 | 0 |
| 30 Sep 14 | 482 | 32 | 74 | 0 |
| 30 Jun 14 | 461 | 31 | 71 | 0 |
| 31 Mar 14 | 443 | 30 | 69 | 0 |
| 31 Dec 13 | 418 | 30 | 66 | 0 |
| 30 Sep 13 | 408 | 30 | 63 | 0 |
Quality Earnings: AHEALTH has high quality earnings.
Growing Profit Margin: AHEALTH's current net profit margins (9.3%) are lower than last year (45.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AHEALTH's earnings have grown significantly by 45.2% per year over the past 5 years.
Accelerating Growth: AHEALTH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AHEALTH had negative earnings growth (-78.6%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-25.1%).
Return on Equity
High ROE: AHEALTH's Return on Equity (11%) is considered low.